"Abstract 2384: Assessment of PITX2, BMP4, FGF4, ERalpha, ERbeta promoter methylation in the circulating tumor cells (CTCs) can predict metastasis and survival in primary invasive duct carcinoma (PIDC) patients",

Citation:
Makar, H. A. S., A. A. Bahnassy, S. E. Salem, and R. M. Gaafar, ""Abstract 2384: Assessment of PITX2, BMP4, FGF4, ERalpha, ERbeta promoter methylation in the circulating tumor cells (CTCs) can predict metastasis and survival in primary invasive duct carcinoma (PIDC) patients",", Cancer Research, vol. 72, issue 8, pp. 2384-2384, 2012.
Tourism